AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
81 hedge funds and large institutions have $61.9M invested in AVEO Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
21% less capital invested
Capital invested by funds: $78.5M → $61.9M (-$16.6M)
96% less call options, than puts
Call options by funds: $7K | Put options by funds: $188K
Holders
81
Holding in Top 10
3
Calls
$7K
Puts
$188K
Top Buyers
| 1 | +$1.03M | |
| 2 | +$860K | |
| 3 | +$755K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$474K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$466K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$1.46M | |
| 3 | -$1.18M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$994K |
| 5 |
ARC
Absolute Return Capital
Boston,
Massachusetts
|
-$907K |